Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab for Crohn's-like IBD in CGD
NCT00325078Phase 2Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- May 2006
- Primary completion
- Jun 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of infliximab in inflammatory bowel disease (IBD), sponsored by National Institute of Allergy and Infectious Diseases. Started May 2006; status: terminated.
02
Drugs
infliximab
03
Conditions
inflammatory bowel disease (IBD)
Beyond the preview
Go deeper on NCT00325078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00325078.